Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 1
1955 2
1957 2
1960 1
1963 1
1964 2
1967 4
1968 9
1970 3
1971 3
1972 2
1973 4
1974 4
1975 11
1976 9
1977 7
1978 9
1979 17
1980 14
1981 7
1982 12
1983 9
1984 11
1985 11
1986 16
1987 18
1988 10
1989 17
1990 8
1991 26
1992 25
1993 12
1994 13
1995 14
1996 19
1997 25
1998 22
1999 21
2000 29
2001 16
2002 23
2003 29
2004 43
2005 24
2006 43
2007 40
2008 49
2009 54
2010 49
2011 56
2012 58
2013 55
2014 61
2015 84
2016 87
2017 66
2018 76
2019 85
2020 92
2021 87
2022 63
2023 65
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

1,581 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D; STEP 4 Investigators. Rubino D, et al. JAMA. 2021 Apr 13;325(14):1414-1425. doi: 10.1001/jama.2021.3224. JAMA. 2021. PMID: 33755728 Free PMC article. Clinical Trial.
RESULTS: Among 803 study participants who completed the 20-week run-in period (with a mean weight loss of 10.6%) and were randomized (mean age, 46 [SD, 12] years; 634 [79%] women; mean body weight, 107.2 kg [SD, 22.7 kg]), 787 participants (98.0%) completed t …
RESULTS: Among 803 study participants who completed the 20-week run-in period (with a mean weight loss of 10.6%) and were randomized …
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
Rubino DM, Greenway FL, Khalid U, O'Neil PM, Rosenstock J, Sørrig R, Wadden TA, Wizert A, Garvey WT; STEP 8 Investigators. Rubino DM, et al. JAMA. 2022 Jan 11;327(2):138-150. doi: 10.1001/jama.2021.23619. JAMA. 2022. PMID: 35015037 Free PMC article. Clinical Trial.
Participants unable to tolerate 2.4 mg of semaglutide could receive 1.7 mg; participants unable to tolerate 3.0 mg of liraglutide discontinued treatment and could restart the 4-week titration. Placebo groups were pooled (n = 85). MAIN OUTCOMES AND MEASURES: The primary end …
Participants unable to tolerate 2.4 mg of semaglutide could receive 1.7 mg; participants unable to tolerate 3.0 mg of liraglutide discontinu …
Physiological adaptations to weight loss and factors favouring weight regain.
Greenway FL. Greenway FL. Int J Obes (Lond). 2015 Aug;39(8):1188-96. doi: 10.1038/ijo.2015.59. Epub 2015 Apr 21. Int J Obes (Lond). 2015. PMID: 25896063 Free PMC article. Review.
Maintenance of body weight is regulated by the interaction of a number of processes, encompassing homoeostatic, environmental and behavioural factors. ...It is difficult to overcome physiology with behaviour. Weight loss medications and surgery change the phy …
Maintenance of body weight is regulated by the interaction of a number of processes, encompassing homoeostatic, environmental …
Health effects of vegan diets.
Craig WJ. Craig WJ. Am J Clin Nutr. 2009 May;89(5):1627S-1633S. doi: 10.3945/ajcn.2009.26736N. Epub 2009 Mar 11. Am J Clin Nutr. 2009. PMID: 19279075 Free article. Review.
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults.
NCD Risk Factor Collaboration (NCD-RisC). NCD Risk Factor Collaboration (NCD-RisC). Lancet. 2017 Dec 16;390(10113):2627-2642. doi: 10.1016/S0140-6736(17)32129-3. Epub 2017 Oct 10. Lancet. 2017. PMID: 29029897 Free PMC article.
BACKGROUND: Underweight, overweight, and obesity in childhood and adolescence are associated with adverse health consequences throughout the life-course. Our aim was to estimate worldwide trends in mean body-mass index (BMI) and a comprehensive set of BMI categories that c …
BACKGROUND: Underweight, overweight, and obesity in childhood and adolescence are associated with adverse health consequences throughout the …
Obesity, male infertility, and the sperm epigenome.
Craig JR, Jenkins TG, Carrell DT, Hotaling JM. Craig JR, et al. Fertil Steril. 2017 Apr;107(4):848-859. doi: 10.1016/j.fertnstert.2017.02.115. Fertil Steril. 2017. PMID: 28366411 Free article. Review.
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.
Garrett-Bakelman FE, Darshi M, Green SJ, Gur RC, Lin L, Macias BR, McKenna MJ, Meydan C, Mishra T, Nasrini J, Piening BD, Rizzardi LF, Sharma K, Siamwala JH, Taylor L, Vitaterna MH, Afkarian M, Afshinnekoo E, Ahadi S, Ambati A, Arya M, Bezdan D, Callahan CM, Chen S, Choi AMK, Chlipala GE, Contrepois K, Covington M, Crucian BE, De Vivo I, Dinges DF, Ebert DJ, Feinberg JI, Gandara JA, George KA, Goutsias J, Grills GS, Hargens AR, Heer M, Hillary RP, Hoofnagle AN, Hook VYH, Jenkinson G, Jiang P, Keshavarzian A, Laurie SS, Lee-McMullen B, Lumpkins SB, MacKay M, Maienschein-Cline MG, Melnick AM, Moore TM, Nakahira K, Patel HH, Pietrzyk R, Rao V, Saito R, Salins DN, Schilling JM, Sears DD, Sheridan CK, Stenger MB, Tryggvadottir R, Urban AE, Vaisar T, Van Espen B, Zhang J, Ziegler MG, Zwart SR, Charles JB, Kundrot CE, Scott GBI, Bailey SM, Basner M, Feinberg AP, Lee SMC, Mason CE, Mignot E, Rana BK, Smith SM, Snyder MP, Turek FW. Garrett-Bakelman FE, et al. Science. 2019 Apr 12;364(6436):eaau8650. doi: 10.1126/science.aau8650. Science. 2019. PMID: 30975860 Free PMC article.
Longitudinal assessments identified spaceflight-specific changes, including decreased body mass, telomere elongation, genome instability, carotid artery distension and increased intima-media thickness, altered ocular structure, transcriptional and metabolic changes, DNA me …
Longitudinal assessments identified spaceflight-specific changes, including decreased body mass, telomere elongation, genome instabil …
A systematic review of the economic value proposition for commercially available nonsurgical weight-loss interventions.
Finkelstein EA, Chodavadia PA, Strombotne K. Finkelstein EA, et al. Obesity (Silver Spring). 2023 Jul;31(7):1725-1733. doi: 10.1002/oby.23760. Epub 2023 May 25. Obesity (Silver Spring). 2023. PMID: 37231621 Review.
Five weight-loss medications (orlistat, liraglutide, naltrexone-bupropion, semaglutide, and phentermine-topiramate), two meal replacement programs (Jenny Craig, Optifast), and one behavioral intervention (Weight Watchers [WW]) that met inclusion criteria were …
Five weight-loss medications (orlistat, liraglutide, naltrexone-bupropion, semaglutide, and phentermine-topiramate), two meal replace …
Recurrent Angioedema.
Ledford DK, Craig TJ. Ledford DK, et al. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1427-1429. doi: 10.1016/j.jaip.2018.05.009. J Allergy Clin Immunol Pract. 2018. PMID: 30033921 No abstract available.
1,581 results